Skip to content

News

Representative Nathaniel Moran (R-TX) Talks Pharmaceutical Competitiveness, Trade Enforcement, and Supply Chain Security

CF in the News

Published on June 30, 2026

Texas Congressman highlights innovation, intellectual property protections, and strategic competition with China at Center Forward’s American Economic Leadership and Trade Summit.

By Ellie Gustafson

Rep. Nathaniel Moran (R-TX) speaks at Center Forward’s Trade Summit on Tuesday, June 9, 2026 in Washington, D.C.


Rep. Nathaniel Moran (R-TX) joined Center Forward’s American Economic Leadership and Trade Summit for a fireside chat examining the intersection of trade policy, pharmaceutical innovation, and national security.

Congressman Moran hammered home the strategic importance of the pharmaceutical and biotechnology sectors, stressing the need to invest in domestic pharmaceutical manufacturing and research to compete with China. He encouraged Congress to pursue policies that encourage innovation, expand manufacturing capacity, and support workforce development in high-growth industries. He noted that these efforts can help create high-quality jobs and attract new investment to East Texas communities, strengthening the region’s role in America’s advanced manufacturing and life sciences economy.

Responding to questions about pharmaceutical-related Section 301 investigations, Congressman Moran expressed support for strong enforcement mechanisms to address unfair trade practices and ensure American companies compete internationally on a level playing field. The Congressman also argued that the United States should use its leverage in global pharmaceutical markets to encourage greater burden-sharing among trading partners. Many countries benefit from access to innovative American medicines, and the Congressman suggested that trade discussions can play an important role in addressing pricing disparities.

The conversation pivoted to intellectual property protections and the role they play in driving innovation. Congressman Moran highlighted the importance of bringing intellectual property assets back to the United States and creating tax incentives for companies to invest domestically.

The discussion underscored a broader challenge facing policymakers—how to strengthen domestic manufacturing, foster innovation, and protect supply chains while competing in an increasingly complex global economy. 

The Congressman’s remarks highlighted the growing consensus that a combination of targeted investment, workforce development, intellectual property protections, and robust trade enforcement will be necessary to ensure the United States remains a global leader in innovation and production. Maintaining America’s leadership in critical industries will require sustained attention from both Congress and the private sector.